Bladder cancer is predicted to become more common and deadly by 2050.
A new study predicts a global spike in men’s cancer and death rates by 2050. Researchers predict an 84 percent increase in cancer diagnoses and a 93 percent increase in cancer deaths worldwide between 2022 and 2050. A study published in a peer-reviewed journal American Cancer Society. This number is expected to increase from 5.4 million in 2022 to 10.5 million in 2050.
To estimate the incidence and mortality of cancer in men, researchers analyzed population data from 185 countries and territories with 30 cancer subtypes. Men smoke and drink more alcohol than women, according to the study’s authors, putting them at increased risk of cancer and cancer-related deaths. Also, men are less likely to be screened for cancer and more likely to be exposed to cancer at work.
Men aged 65 and older have lower survival rates than younger men because they are less tolerant to treatment and are diagnosed later in the disease, the study authors said. Also, some of them could not afford medical expenses. Cancer deaths among older men are projected to rise from 3.4 million to 7.7 million over the same period, while cancer cases are expected to rise from 6 million in 2022 to 13.1 million in 2050.
The researchers also identified differences in cancer outcomes according to the economic status of different countries. “Between 2022 and 2050, the number of incidents and deaths is projected to increase 2.5-fold in Africa and the Eastern Mediterranean. In contrast, Europe is projected to increase by about one and a half times,” the researchers wrote.
Lung cancer is projected to be the leading cause of cancer and deaths worldwide by 2050, with a growth of more than 87 percent from 2022 to 2050. This is followed by prostate and colon cancer.
With bladder cancer predicted to become more common and deadly by 2050, skin cancer may cause more deaths.
According to the researchers, improving existing cancer outcomes and preparing for the predicted increase by 2050 requires better healthcare infrastructure and access, including an adequate workforce. They also noted that low-income countries suffer from low universal health coverage and disproportionately. due to adverse cancer outcomes. They concluded that expanding universal health coverage could strengthen “fundamental cancer care options.”
